Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation

Vaccine

Volumn 18, Issue 25, 2000, Pages 2779-2788

  Kadowaki, Shin Etsu ^a,b   Chen, Ze ^a   Asanuma, Hideki ^a   Aizawa, Chikara ^c   Kurata, Takeshi ^a   Tamura, Shin Ichi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KYORIN PHARMACEUTICAL CO LTD   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

DNA vaccine; Electroporation; Hemagglutinin; Influenza

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ELECTROPORATION; FEMALE; GENE TARGETING; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MOUSE; MUSCLE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; VIRUS TITRATION;

EID: 0034659609     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00087-6     Document Type: Article

References (32)

1. Ulmer J.B., Donnelly J.J., Paker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by infection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
2. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
3. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemmagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
4. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemmagglutinin. Vaccine. 12:1994;1495-1498.
5. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541-1544.
6. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
7. Aihara H., Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16:1998;867-870.
8. Murphy B.R., Webster R.G. Orthomyxoviruses. Straus S.E. Virology. 1996;1397 Lippincott-Ravan, Philadelphia.
9. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:1995;583-587.
10. Ban E.M., van Ginkel F.W., Simecka J.W., Kiyono H., Robinson H.L., McGhee J.R. Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine. 15:1997;811-813.
11. Tamura S.-I., Funato H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., Kurata T. Cross-protection aginst influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemmagglutinin molecules. Eur. J. Immunol. 21:1991;1337-1344.
12. Tamura S.-I., Asanuma H., Ito Y., Hirabayashi H., Suzuki Y., Nagamine T., Aizawa C., Kurata T., Oya A. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol. 22:1992;477-481.
13. Johansson B.E., Kilbourne E.D. Immunization with purified N1 and N2 influenza virus neuraminidase demonstrates cross-reactivity without antigenic competition. Proc. Natl. Acad. Sci. USA. 91:1994;2358-2361.
14. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahen B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
15. Lundholm P., Asakura Y., Hinkula J., Lucht E., Wahren B. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine. 17:1999;2036-2042.
16. Chen Z., Sahashi Y., Matuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S.-I. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine. 16:1998;1544-1549.
17. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
18. Tamura S.-I., Ito Y., Asanuma H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., Kurata T. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 149:1992;981-988.
19. Phelan M.A., Mayner R.E., Bucker D.J., Ennis F.A. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J. Biol. Stand. 8:1980;233-242.
20. Yetter R.A., Lehrer S., Ramphal R., Small P.A. Jr. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immunol. 29:1980;654-662.
21. Tobita K., Sugiura A., Enomoto C., Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. 162:1975;9-14.
22. Bennink J.R., Yewdell J.W., Smith G.L., Moss B. Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J. Virol. 786-791:1986.
23. Bender B.S., Ulmer J.B., DeWitt C.M., Cottey R., Taylar S.F., Ward A.M., Friedman, A, Liu M.A., Donnelly J.J. Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice. Vaccine. 16:1998;1748-1755.
24. Asanuma H., Inaba Y., Aizawa C., Kurata T., Tamura S. Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J. Immunol. Methods. 187:1995;41-51.
25. Tamura S.-I., Miyata K., Matsuo K., Asanuma H., Takahashi H., Nakajima K., Suzuki Y., Aizawa C., Kurata T. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J. Immunol. 156:1996;3892-3900.
26. Yap K.L., Ada G.L. The recovery of mice from influenza A virus infection: Adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen. Scand. J. Immunol. 8:1978;413-420.
27. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
28. Chen Z., Yoshikawa T., Kadowaki S., Hagiwara Y., Matsuo K., Asanuma H., Aizawa C., Kurata T., Tamura S.-I. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus hemagglutinin, neuraminidase and nucleoprotein. J. Gen. Virol. 80:1999;2559-2564.
29. Tamura S.-I., Samegai Y., Kurata H., Kikuta K., Nagamine T., Aizawa C., Kurata T. Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine. 7:1989;257-262.
30. Gizurarson S., Tamura S.-I., Aizawa C., Kurata T. Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine. 10:1992;101-106.
31. Heller R., Jaroszeski M.J., Glass L.F., Messina J.L., Rapaport D.P., DeConti R.C., Fenske N.A., Gilbert R.A., Mir L.M., Reintgen D.S. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77:1996;964-971.
32. Hofmann G.A., Dev S.B., Dimmer S., Nanda G.S. Electroporation therapy: a new approach for the treatment of head and neck cancer. IEEE Trans. Biomed. Eng. 46:1999;752-759.